Neogap chosen for Innovate Nordics 2025 Acceleration Programme
May 1, 2025Research and Development Innovate Nordics, Neogap Therapeutics, Oncology, biotech, funding programme, immunotherapy
Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics’ 2025 acceleration programme, a prestigious initiative designed to …
Cervical cancer experts campaign to increase screening rates and save lives
April 30, 2025Research and Development NHS, NHS England, Oncology, campaign, cervical cancer, screening
A coalition of experts fighting to end cervical cancer, referred to as the UK Consensus Group of the Advancing Cervical …
Novo Nordisk Foundation expands ambitious Challenge Programme internationallyÂ
April 30, 2025Research and Development Challenge Programme, Denmark, Novo Nordisk, Pharmacy, international
The Novo Nordisk Foundation Challenge Programme, a leading open competition grant programme, invites researchers outside of Denmark to participate and …
Gifthealth appoints Chip Parkinson as CEO to lead next phase of growth
April 29, 2025Business Services, Pharmaceutical Consultancy Services CEO, Gifthealth, Pharmacy, pharmacy care
Gifthealth, a technology-driven pharmacy care company, has appointed Chip Parkinson as its new chief executive officer. The move marks a …
Ryan Smith appointed as global head of sales at Astoriom
April 29, 2025Logistics & Distribution, Research and Development Astoriom, Pharmacy, appointment, sample storage solutions
Global R&D sample stability and biorepository storage company, Astoriom, has announced the appointment of Ryan Smith as global head of …
EU approval granted for rare kidney disease treatment
April 29, 2025Market Access, Research and Development, Sales and Marketing CSL Vifor, EU, Nephrology, Travere Therapeutics, kidney disease, nephrology
The EU has granted marketing authorisation (MA) for Filspari – CSL Vifor and Travere Therapeutics’ therapy for primary IgA nephropathy …
Study finds new test could better predict risk of heart disease
April 28, 2025Research and Development Cardiology, Chalmers University of Technologyu, Harvard, cholesterol tests, cvd
A study by Harvard University, US, and Chalmers University of Technology, Sweden, has found that measuring a lipoprotein marker combination …
Sobi and Sanofi’s Foundation S renew partnership with World Federation of Hemophilia
April 28, 2025Pharmacy sales & educational programmes, Sales and Marketing Haematology, Sanofi, World Federation of Hemophilia, bleeding disorder, sobi
Sobi and Sanofi, through its organisation Foundation S, have extended their partnership with the World Federation of Hemophilia (WFH) Humanitarian …
McDavid Stilwell appointed as CFO of CPTx
April 28, 2025Research and Development CPTx, Immunology, Oncology, appointment, cfo, therapeutics
CPTx, a German biotech company focused on single-stranded DNA therapeutics, has announced the appointment of McDavid Stilwell as chief financial …
Pharma supply chain event LogiPharma celebrates another successful year
April 28, 2025Industry Associations, Medical Communications Cold Chain Technologies, DB Schenker, LogiPharma, Pharmacy, PluumoPlus, supply chain event, supply chain professionals
In Lyon, France, over 2,200 life sciences supply chain professionals gathered for LogiPharma 2025, a leading conference dedicated to supply …
Successful clinical outcomes for drug treating rare stroke condition
April 25, 2025Research and Development Bioxodes, Neurology, clinical trial, stroke
Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral …
Mosaic Therapeutics in-licenses clinical oncology programmes from Astex Pharma
April 25, 2025Clinical Trial Services, Industry Associations, Mergers and Acquisitions, Research and Development Astex pharmaceuticals, Mosaic Therapeutics, Oncology, clinical trial
Two clinical-stage oncology programmes from Astex Pharmaceuticals have been announced by Mosaic Therapeutics, allowing it to develop targeted oncology drug …
Philippe Masset appointed to Vect-Horus board of directors
April 25, 2025Research and Development Oncology, Vect-Horus, appointment, board of directors, imaging agents
Vect-Horus has announced the appointment of Philippe Masset to the company’s board of directors. This contributes to a series of …
Mursla Bio’s platform for surveillance of liver cancer receives FDA approval
April 24, 2025Industry Associations, Research and Development BDD, FDA, Mursla Bio, Oncology, hepatocellular carcinoma (HCC), liver disease
The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bio’s surveillance platform for …
Hansa Biopharma appoints Renée Aguiar-Lucander as CEO
April 24, 2025Research and Development CEO, Corporate, Hansa Biopharma, appointment, immunology
Swedish biopharma company, Hansa Biopharma, has announced the appointment of new chief executive officer (CEO) Renée Aguiar-Lucander, replacing Søren Tulstrup …
Neurizon makes appointments to executive team
April 24, 2025Recruitment, Senior Management Neurizon, Neurology, als, biotech, neurodegenerative diseases
Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support …
ViroCell and UCL launch trial to treat childhood leukaemia relapse
April 24, 2025Research and Development Oncology, UCL, ViroCell, acute lymphoblastic leukaemia, cell therapy, clinical trial, leukaemia
ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse …
Dual immunotherapy for bowel cancer now available under NHS
April 23, 2025Research and Development Bristol Myer Squibb, MHRA, NICE, Oncology, bowel cancer, colorectal cancer, immunotherapy
Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in the UK by the Medicines …
CARBOGEN AMCIS manufacturing license advances services in China
April 23, 2025Manufacturing Services, Manufacturing and Production Carbogen Amcis, China, Corporate, Drug Manufacturing License (DML), Shanghai, manufacturing
Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has been successfully granted Drug Manufacturing …
AOTI diabetic foot care therapy to be used by NHS
April 23, 2025Research and Development AOTI, Diabetes, diabetes, diabetic foot care, health economic study
Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in the NHS supply chain. It …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
